Clinical trial
Pharmacodynamic Effects of Sibutramine on Gastric Function in Obesity
NCT00330525 · Mayo Clinic, Other · Completed
Key facts
| NCT number | NCT00330525 |
|---|---|
| Title | Pharmacodynamic Effects of Sibutramine on Gastric Function in Obesity |
| Official title | Pharmacodynamic Effects of Sibutramine on Gastric Function in Obesity |
| Lead sponsor | Mayo Clinic, Other |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Obesity, Overweight |
| Intervention type | Drug |
| Interventions | sibutramine |
| Enrollment | 72 |
| Start date | Jan 1, 2005 |
| Primary completion | Mar 1, 2006 |
| Completion | Mar 1, 2006 |
| First posted | May 29, 2006 |
| Last update posted | Jan 20, 2010 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: